Introduction: In Europe and in North America, portal hypertension accompanies cirrhosis of the liver in over 90 % of the cases. Cirrhosis of the liver is caused by alcohol abuse in about half of the cases; a third is due to chronic viral hepatitis B and C; and the remainder is the result of various metabolic or idiopathic disorders of the liver. Transjugular intrahepatic portosystemic shunting, as a percutaneous alternative to surgical portosystemic shunts for decompression of symptomatic portal hypertension, was conceived and its technique developed in animal experiments in the late 1960s by Rosch et al. CardioVascular and Interventional Radiology December 2012, Volume 35, Issue 6, pp 1295-1300. Copyright © Springer Science+Business Media, LLC and the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) 2012
Preamble: The membership of the Society of Interventional Radiology (SIR) Standards of Practice Committee represents experts in a broad spectrum of interventional procedures from both the private and academic sectors of medicine. Generally Standards of Practice Committee members dedicate the vast majority of their professional time to performing interventional procedures; as such they represent a valid broad expert constituency of the subject matter under consideration for standards production. Journal of Vascular and Interventional Radiology Volume 22, Issue 11 , Pages 1499-1506, November 2011. Copyright © 2011 SIR. Published by Elsevier Inc. All rights reserved.
Major hepatectomy carries a significant risk of mortality. In patients with normal liver bearing metastases, mortality after major hepatectomy ranges from 0.5% to 4%, but in patients [1] with chronic liver disease, such as cholestatic or cirrhotic liver, mortality increases to 4% to 12% [2, 3]. The main cause of mortality as well as postoperative morbidity after major hepatic resection is liver insufficiency, often due to an insufficient liver remnant volume [4, 5].
The incidence of lung cancers continues to increase, and primary lung cancer remains the primary cause of cancerrelated deaths in both women and men [1]. There are two main types of lung cancers: small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC). The latter is further divided into squamous cell carcinoma, adenocarcinoma, and large cell carcinoma. Treatments of primary lung cancers include surgical resection (including sublobar or wedge resection), radiotherapy (including three-dimensional conformal radiation or stereotactic body radiotherapy), chemotherapy, thermal ablation, or a combination of these treatment modalities.
Transarterial chemoembolization (TACE) was first introduced in 1977 by Dr. Yamada, who exploited hepatocellular carcinoma’s (HCC) preferential blood supply from the hepatic artery for the delivery of antitumor therapy. His findings on an initial cohort of 120 patients were published in the English literature in 1983 [1].
Introduction: Thrombolytic therapy has been an established and effective treatment for acute limb ischemia for years [1–3]. The treatment options for this life-threatening condition are ‘‘open’’ surgery, percutaneous endovascular treatment, and intravenous (i.v.) systemic thrombolysis. Current percutaneous treatment includes catheter-mediated infusion of fibrinolytic agents (pharmacological thrombolysis), pharmacomechanical thrombolysis, catheter-mediated thrombus aspiration, mechanical thrombectomy, and a combination of the above [4–10]. This study was designed to quality assurance guidelines concerning the treatment of acute and subacute arterial limb ischemia, with the use of percutaneous catheter-directed pharmacological thrombolysis and mechanical thrombectomy or a combination of both.
Chronic cerebrospinal venous insufficiency (CCSVI) is a putative new theory that has been suggested by some to have a direct causative relation with the symptomatology associated with multiple sclerosis (MS) [1]. The core foundation of this theory is that there is abnormal venous drainage from the brain due to outflow obstruction in the draining jugular vein and/or azygos veins.
Abstract: Isolated iliac artery aneurysms are uncommon, comprising less than 2% of all abdominal aneurysmal disease. Although they have a fairly innocuous natural history, when they have attained a large size they carry a significant risk of rupture. Rupture is associated with significant morbidity and mortality. Therefore, an early diagnosis and treatment are crucial. Over the last decade, interventional treatment options have become established alternatives to open surgical repair. These guidelines aim to review the pathogenesis, natural history, and presentation of isolated iliac artery aneurysms including a description of imaging and interventional treatment strategies.
The membership of the Society of Interventional Radiology (SIR) Standards of Practice Committee represents experts in a broad spectrum of interventional procedures from the private and academic sectors of medicine. Generally, Standards of Practice Committee members dedicate the vast majority of their professional time to performing interventional procedures; as such, they represent a valid broad expert constituency of the subject matter under consideration for standards production. Journal of Vascular and Interventional Radiology Volume 23, Issue 3 , Pages 287-294, March 2012. Copyright © SIR, 2012
This quality improvement guideline outlines the place of interventional radiology (IR) in trauma management and indicates how imaging and IR can be used in the context of hemorrhage in the severely injured patient, and when IR is appropriate and when it is contraindicated.
Thrombolytic therapy has been an established and effective treatment for acute limb ischemia for years [1–3]. The treatment options for this life-threatening condition are ‘‘open’’ surgery, percutaneous endovascular treatment, and intravenous (i.v.) systemic thrombolysis. Current percutaneous treatment includes catheter-mediated infusion of fibrinolytic agents (pharmacological thrombolysis), pharmacomechanical thrombolysis, catheter-mediated thrombus aspiration, mechanical thrombectomy, and a combination of the above [4–10]. This study was designed to quality assurance guidelines concerning the treatment of acute and subacute arterial limb ischemia, with the use of percutaneous catheter-directed pharmacological thrombolysis and mechanical thrombectomy or a combination of both. Cardiovasc Intervent Radiol (2011) 34:1123–1136. Copyright Springer Science+Business Media, LLC and the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) 2011
Introduction Different image-guided percutaneous techniques can be used for treatment or pain palliation in patients with primary or secondary bone tumours. Curative ablation can be applied for the treatment of specific benign or in selected cases of malignant localized bone tumours [1]. Pain palliation therapy of primary and secondary bone tumours [2, 3] can be achieved with safe, fast, effective, and tolerable percutaneous methods [4]. Ablation (chemical, thermal, mechanical), cavitation (radiofrequency ionization), and consolidation (cementoplasty) techniques can be used separately or in combination. Each technique has its indications as well as its own advantages and drawbacks.
The National Institute for Health and Clinical Excellence (NICE) has issued full guidance to the NHS in England, Wales, Scotland and Northern Ireland on Percutaneous transluminal radiofrequency sympathetic denervation of the renal artery for resistant hypertension. © National Institute for Health and Clinical Excellence, 2012. All rights reserved. This material may be freely reproduced for educational and not-for-profit purposes. No reproduction by or for commercial organisations, or for commercial purposes, is allowed without the express written permission of NICE.
The National Institute for Health and Clinical Excellence (NICE) has issued full guidance to the NHS in England, Wales, Scotland and Northern Ireland on Stent insertion for bleeding oesophageal varices. It replaces the previous guidance on stent insertion for bleeding oesophageal varices (Interventional Procedures Guidance no. 265 June 2008). © National Institute for Health and Clinical Excellence, 2011. All rights reserved. This material may be freely reproduced for educational and not-for-profit purposes. No reproduction by or for commercial organisations, or for commercial purposes, is allowed without the express written permission of NICE.
The National Institute for Health and Clinical Excellence (NICE) has issued full guidance to the NHS in England, Wales, Scotland and Northern Ireland on Selective internal radiation therapy for non-resectable colorectal metastases in the liver. It replaces the previous guidance on Selective internal radiation therapy for colorectal metastases in the liver (Interventional Procedures Guidance no.93 September 2004). © National Institute for Health and Clinical Excellence, 2011. All rights reserved. This material may be freely reproduced for educational and not-for-profit purposes. No reproduction by or for commercial organisations, or for commercial purposes, is allowed without the express written permission of NICE.
Cookies Sociales
Son esos botones que permiten compartir el contenido del sitio web en sus redes sociales (Facebook, Twitter y Linkedin, previo tu consentimiento y login) a través de sistemas totalmente gestionados por dichas redes sociales, así como los recursos (pej. videos) y material que se encuentra en nuestra web, y que de igual manera se presta y gestiona completamente por un tercero.
Si no acepta estas cookies, no podrá compartir nuestro contenido a través de los botones, y en su caso, no podrás visualizar el contenido de terceros que hayamos incrustado en el sitio.
No las utilizamos